PAVM · All filings · Read this filing

What changed 10-Q

Item 5. Other Information

2023-08-14 compared with 2023-05-15 · 0 added, 10 removed, 20 unchanged (33% of the section changed)

7 unchanged sentences

Incorporation

Form of Senior Secured Convertible Promissory Note (LUCD)

Termination Agreement, dated as of February 10, 2023, by and among Lucid Diagnostics Inc., LucidDx Labs Inc.

and ResearchDx, Inc.

Registration Rights Agreement, dated as of March 7, 2023, by and among Lucid Diagnostics Inc.

and the purchases of Series A Preferred Stock party thereto

(Preferred Offering) (LUCD)

Form of Securities Purchase Agreement

Form of Guaranty

Form of Registration Rights Agreement

Form of Voting Agreement

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

11 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.